Sg Americas Securities, LLC Bio Rad Laboratories, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 1,255 shares of BIO stock, worth $428,595. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,255
Previous 1,862 32.6%
Holding current value
$428,595
Previous $509,000 17.49%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
SELL
$263.97 - $344.64 $160,229 - $209,196
-607 Reduced 32.6%
1,255 $420,000
Q2 2024

Jul 12, 2024
SELL
$268.26 - $339.48 $1.32 Million - $1.67 Million
-4,930 Reduced 72.59%
1,862 $509,000
Q1 2024

May 06, 2024
BUY
$304.11 - $351.99 $1.54 Million - $1.78 Million
5,049 Added 289.67%
6,792 $2.35 Million
Q4 2023

Jan 12, 2024
BUY
$269.37 - $365.04 $469,511 - $636,264
1,743 New
1,743 $563,000
Q2 2023

Jul 10, 2023
SELL
$359.49 - $486.4 $216,772 - $293,299
-603 Reduced 34.3%
1,155 $438,000
Q1 2023

Apr 28, 2023
BUY
$418.69 - $503.0 $63,640 - $76,456
152 Added 9.46%
1,758 $842,000
Q4 2022

Feb 02, 2023
SELL
$351.71 - $456.01 $758,990 - $984,069
-2,158 Reduced 57.33%
1,606 $675,000
Q3 2022

Oct 31, 2022
BUY
$412.59 - $563.26 $1.32 Million - $1.8 Million
3,188 Added 553.47%
3,764 $1.57 Million
Q2 2022

Jul 29, 2022
SELL
$463.67 - $597.16 $497,054 - $640,155
-1,072 Reduced 65.05%
576 $285,000
Q1 2022

Apr 29, 2022
SELL
$524.57 - $735.42 $8.8 Million - $12.3 Million
-16,767 Reduced 91.05%
1,648 $928,000
Q4 2021

Feb 07, 2022
BUY
$708.84 - $794.68 $10.7 Million - $12 Million
15,146 Added 463.32%
18,415 $13.9 Million
Q3 2021

Nov 01, 2021
SELL
$657.71 - $825.77 $4.22 Million - $5.3 Million
-6,420 Reduced 66.26%
3,269 $2.44 Million
Q2 2021

Aug 12, 2021
BUY
$576.64 - $649.04 $3.69 Million - $4.15 Million
6,394 Added 194.05%
9,689 $6.24 Million
Q1 2021

May 13, 2021
BUY
$547.01 - $662.35 $394,394 - $477,554
721 Added 28.01%
3,295 $1.88 Million
Q4 2020

Feb 04, 2021
BUY
$510.68 - $643.45 $931,991 - $1.17 Million
1,825 Added 243.66%
2,574 $1.5 Million
Q3 2020

Nov 09, 2020
SELL
$454.43 - $535.6 $523,503 - $617,011
-1,152 Reduced 60.6%
749 $386,000
Q2 2020

Jul 20, 2020
SELL
$334.87 - $493.06 $48,556 - $71,493
-145 Reduced 7.09%
1,901 $858,000
Q1 2020

Apr 30, 2020
BUY
$320.01 - $409.07 $92,482 - $118,221
289 Added 16.45%
2,046 $717,000
Q4 2019

Jan 28, 2020
BUY
$319.73 - $374.2 $81,850 - $95,795
256 Added 17.06%
1,757 $650,000
Q3 2019

Nov 04, 2019
SELL
$304.55 - $345.24 $126,083 - $142,929
-414 Reduced 21.62%
1,501 $499,000
Q2 2019

Jul 29, 2019
SELL
$286.93 - $312.59 $57,959 - $63,143
-202 Reduced 9.54%
1,915 $599,000
Q1 2019

Apr 29, 2019
BUY
$224.3 - $317.41 $299,216 - $423,424
1,334 Added 170.37%
2,117 $647,000
Q4 2018

Feb 01, 2019
SELL
$220.1 - $309.0 $330,370 - $463,809
-1,501 Reduced 65.72%
783 $182,000
Q3 2018

Nov 06, 2018
SELL
$289.28 - $326.15 $138,565 - $156,225
-479 Reduced 17.34%
2,284 $715,000
Q2 2018

Aug 07, 2018
SELL
$244.1 - $303.88 $102,522 - $127,629
-420 Reduced 13.2%
2,763 $797,000
Q1 2018

May 03, 2018
SELL
$233.97 - $274.11 $1.57 Million - $1.84 Million
-6,700 Reduced 67.79%
3,183 $796,000
Q4 2017

Jan 24, 2018
BUY
$216.94 - $271.3 $1.98 Million - $2.48 Million
9,138 Added 1226.58%
9,883 $2.36 Million
Q3 2017

Nov 07, 2017
BUY
$212.27 - $242.28 $158,141 - $180,498
745
745 $166,000

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email